CD274 and colorectal neoplasm: 89Zr-DFO-anti-PD-L1-mAb tracers with a CAR of 1.4 to 2.0 may have a stronger ability to image PD-L1 expression in colorectal tumors than traditional low-CAR 89Zr-iPET tracers.